Birth Defects Linked to Zofran

Zofran is a medication approved by the FDA to alleviate nausea during chemotherapy and following surgery. GlaxoSmithKline, the manufacturer of Zofran, has additionally promoted an off-label use of Zofran for morning sickness in pregnant woman. To date, there have been almost 500 reports of birth defects linked to women’s use of Zofran during pregnancy. These women have given birth to babies with defects, such as cleft palate and septal heart defects.

Contact a Toledo Injury Attorney

If you have been prescribed Zofran for morning sickness and subsequently gave birth to a baby with a birth defect, contact the experienced Toledo personal injury attorneys at Williams DeClark Tuschman for a free consultation.